Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GNB1 divergent transcript (GNB1-DT) is a human long non-coding RNA (lncRNA) located near the protein-coding GNB1 gene. According to the HUGO Gene Nomenclature Committee, "divergent transcripts" are a class of long non-coding RNAs that reside within a short genomic distance of a protein-coding gene, typically in a head-to-head (divergent) orientation, and may have regulatory potential. There is minimal published functional or clinical information about GNB1-DT. Some gene databases incorrectly alias GNB1-DT with "collagen alpha-2(VIII) chain," which actually refers to the COL8A2 protein unrelated to GNB1-DT. There are no known drugs, biomarkers, or established therapeutic relevance for GNB1-DT.
Not applicable (not a protein target).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GNB1 divergent transcript (GNB1-DT).